Swiss drugmaker will make a gene-based Covid-19 vaccine being developed by researchers at Massachusetts Eye and Ear hospital, Massachusetts General Hospital and the University of Pennsylvania
Novartis AG has agreed to manufacture a gene-based coronavirus vaccine being developed by scientists at Massachusetts Eye and Ear hospital, Massachusetts General and the University of Pennsylvania, paving the way for human testing to begin later this year.
The Swiss drugmaker’s gene therapy unit AveXis is already making test batches of the vaccine and plans to start producing doses later in the summer that can be used for a clinical trial, said Dave Lennon, the unit’s president.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Stock market live Tuesday: Dow surges 500, JPM jumps on Dimon comment, China worries ruin the close“We’ve widened the gap between large and small” businesses under coronavirus lockdowns, Wharton’s Jeremy Siegel said yesterday. “It was almost a capitalist dream.”
Consulte Mais informação »
L.A. County will ask state to allow restaurants, other businesses to reopen soonerL.A. County supervisors say the county has made enough progress in dealing with the coronavirus that they will ask the state to allow more establishments to begin reopening.
Consulte Mais informação »
Defense secretary says coronavirus vaccine will be available within months, but experts skepticalPentagon leaders expressed strong confidence Thursday that a coronavirus vaccine will be available by January, and possibly as early as this fall — claims that were met with skepticism by scientific experts.
Consulte Mais informação »
‘Vaccine Nationalism’: A New Dynamic in the Race to Quash CoronavirusPharmaceutical companies are bracing for export bans on future coronavirus vaccines and spreading production across different continents, on early signs of a geopolitical scramble to secure supplies.
Consulte Mais informação »
Treasury yields edge lower as US-China tensions cool investor optimismU.S. government debt prices inched higher Wednesday morning as U.S. concerns on new Hong Kong security laws cooled investor sentiment over economic reopening and a possible coronavirus vaccine.
Consulte Mais informação »